Accelerating Innovation in the Creation of Biovalue
The Cell and Gene Therapy Catapult
Bibliographic Data
| ID | 5337075 |
|---|---|
| Authors | John Gardner (0000-0001-7417-348X, Monash University, corresponding author), Andrew Webster (0000-0002-5782-0793, University of York) |
| Year | 2017 |
| Volume | 42 |
| Issue | 5 |
| Pages | 925-946 |
| Publication date | 2017-09-01 |
| Peer Reviewed | Yes |
| Open Access | Yes |
| Type | ARTICLE |
| Venue | Science Technology & Human Values (JOURNAL) |
| Journal identifiers | ISSN: 0162-2439 • E-ISSN: 1552-8251 |
| Publisher | SAGE Publications Inc (PUBLISHER) |
| DOI | 10.1177/0162243917702720 |
| PMID | 28845068 |
| OpenAlex | W2604485580 |
| Language | EN |
| Citations received | 19 |
| References cited | 28 |
The field of regenerative medicine (RM) has considerable therapeutic promise that is proving difficult to realize. As a result, governments have supported the establishment of intermediary agencies to "accelerate" innovation. This article examines in detail one such agency, the United Kingdom's Cell and Gene Therapy Catapult (CGTC). We describe CGTC's role as an accelerator agency and its value narrative, which combines both "health and wealth." Drawing on the notion of sociotechnical imaginaries, we unpack the tensions within this narrative and its instantiation as the CGTC cell therapy infrastructure is built and engages with other agencies, some of which have different priorities and roles to play within the RM field
Engineering ethics · Knowledge management · Narrative · Political science · Public relations · Social science · Sociology · Sociotechnical system · Biomedical Ethics and Regulation · Computer Science · Engineering · Pluripotent Stem Cells Research · Science, Research, and Medicine
Participation in SoHO and ATMP public consultations
Birch, Kean, We Have Never Been Neoliberal
Translating cell biology of ageing? On the importance of choreographing knowledge
Imagining the future of cell therapies
Bioprinting as a Sociotechnical Project
Organoids at the forefront of global health
A precision immuno-oncology turn? Hybridizing cancer genomics and immunotherapy through neoantigens-based adoptive cell therapies
Unboxing the imaginary
Imaginaries of the data-driven hospital in a time of crisis
Resisting big data exploitations in public healthcare
Performativity of expectations
Imagining Technology-Mediated Social Change? A Critique of the Theory of Sociotechnical Imaginaries
Reimagining Health as a ‘Flow on Effect’ of Biomedical Innovation
Imaginaries as infrastructures? The emergence of non-invasive prenatal testing in Austria
Rethinking value construction in biomedicine and healthcare
The promise of precision
Leading the Future by Creating it’
Fresh or Thawed T Cells
Accomplishing an adaptive clinical trial for cancer
Is Science a Public Good? Fifth Mullins Lecture, Virginia Polytechnic Institute, 23 March 1993
India-EU relations in health services
State strategies of governance in biomedical innovation
Promissory futures and possible pasts
Bench, bedside, boardroom
Institutional Imaginaries of Publics in Stem Cell Banking
The UK Stem Cell Bank
Containing the Atom
Rethinking Value in the Bio-economy
Stem Cells, Tissue Cultures and the Production of Biovalue
Best research - For what? Best health - For whom? A critical exploration of primary care research using discourse analysis
The social management of biomedical novelty
State Strategies and the Geopolitics of the Global Knowledge Economy
Promissory identities
Actor-Network Theory-The Market Test
Closing the regulatory regress
| Unique citing works | 19 |
|---|---|
| Citations per year | 2,11 |
| Citation span | 2017 - 2026 (10) |
| Citation velocity | current |
| Highly cited | No |
| Citation types | Neutral: 19 |